the reaction between the HIV-1 envelope glycoprotein gp120 and antibodies specific for the V3 hypervariable loop of this glycoprotein were an enticement to determine whether or not additional porphyrins had similar activities. Several porphyrin derivatives, particularly meso-tetra (4-carboxyphenyl) porphine, were more potent inhibitors of HIV-1 replication than haemin. They blocked the binding of homologous antibodies to synthetic peptides corresponding to V3 hypervariable loops of 21 distinct HIV-1 isolates, and inhibited the replication in lymphocytic (MT-2) and promonocytic (U937) cell lines of several HIV-1 isolates, tested (illS, RF, SF-2, and MN). Compounds with inhibitory activity had a tetrapyrrole ring and, carboxyl or sulphonate groups. However, antiviral activity depended on minor structural differences between distinct derivatives endowed with these two features. Metalloporphyrins had a drastically reduced antiviral activity in comparison with the corresponding porphyrins. An understanding of the relationship between the structure of porphyrins and their antiviral effects, perceptible from the results presented, is expected to lead to the design of additional derivatives with more potent antiviral activity and to unravelling of molecular details involved in the association between the V3100p of gp120 and antiviral compounds targeted to this loop.
Introduction
A rapid prescreening method for antiviral agents against HIV-1, based on their inhibitory activity in site-directed immunoassays, measuring the attachment of antibodies specific for the V3 hypervariable loop of the HIV-1 envelope glycoprotein gp120 to gp120, was developed recently (Neurath et et., 1991a) . A majority of substances having inhibitory activity in these immunoassays (>2/3), also inhibited the replication of HIV-1 IIIB. One of the substances identified by this prescreening method was haemin, shown earlier to inhibit the replication of HIV-1 (Levere et al., 1991) . The availability of a multitude of porphyrin derivatives enticed us to study their binding to the V3 loop of gp120 and their antiviral activity in order to find derivatives with more potent antiviral activity than that of haemin, establish a relationship between antiviral activity and the structure of a group of chemically closely related substances, and to determine whether or not selected derivatives with antiviral activity against the prototype HIV-1 IIIB would also inhibit the replication of other HIV-1 isolates which differ in the primary amino acid sequence of the V3 loop from the BH-10 (1IIB) V3 loop. Results of these studies show that some of the porphyrin derivatives are potent inhibitors of replication of several HIV-1 isolates in both T lymphocytic and monocytic cell lines, which indicates their potential usefulness for chemotherapy of HIV-1 infections.
ReSUlts

Porphyrins differ greatly in their inhibitory activity on the reaction of antibodies specific for the V3 hypervariable loop with gp120, and on HIV-1 replication
The V3 hypervariable loop of HIV-1-IIIB is the most positively charged segment within the entire sequence of gp120 (Neurath et el., 1991a) , and V3100ps of other HIV-1 isolates also have a net positive electric charge (Fig. 1c ). Therefore, it was considered likely that porphyrin derivatives with a net negative electric charge would bind to V3 loops of gp120 and display antiviral activity. Haemin (ferriprotoporphyrin IX chloride) shown to inhibit HIV-1 replication (Levere et al., 1991; Neurath et al., 1991) and Meso-tetra (4-carboxyphenyl) porphine Fig. 1 . Inhibitory effect of deuteroporphyrin IX, 2,4 (4,2) hydroxyethylvinyl (A) and of meso-tetra (4carboxyphenyl) porphine (B) on the reaction of full-Ienqth V3 hypervariable loop peptides from gp120 from 21 distinct HIV-1 isolates (clones) With homologous anti-peptide antisera. Peptide coated wells of polystyrene plates were reacted in the presence and absence of the inhibitory compounds with the respective rabbit antisera diluted 1 : 1000, and the attachment of rabbit IgG was subsequently determined using 1251-labelled anti-rabbit IgG. The net electric charge of the peptides, determined by subtracting the number of aspartic (D) and glutamic (E) acid residues from the sum of lysine (I<) and arginine (R) residues, is shown in panel C. the binding of antibodies to the V3 hypervariable loop (Neurath et al., 1991a) has two carboxyl groups (Fig. 2 ). So it was considered more likely that other porphyrins with carboxyl residues would have greater antiviral activity compared to porphyrin derivatives which lack such groups. For this reason, porphyrins with carboxyl residues were preferentially selected for testing of their inhibitory activity on the gp120-anti-V3 loop antibody reaction. Unexpectedly, large differences in both inhibitory activity for gp120-antibody reactions and for viral replication were found among such derivatives (compounds 2, 3, 4a, 5, 6, 7a, 8-13, 16,21, and 22a ; Table 1 ). The most potent inhibitors of HIV-1-IIIB replication were meso-tetra (4-carboxyl-phenyl) porphine (#16) and N-methyl protoporphyrin IX (#12) (# indicates compound number). These two substances had the highest selectivity index (SI) as a result of their high antiviral activity, and the lowest cytotoxicity for uninfected cells. Differences between antiviral activity of these porphyrin derivatives made it possible to attempt to establish a structure functionrelationship for these compounds (see Discussion). Pyrrole derivatives lacking the porphyrin ring structure (#11, mesobilirubin) and #15 (rhodotorulic acid) had no inhibitory activity on gp120-anti-V3 loop antibody reactions. A porphyrin with sulphonate rather than carboxylate residues had diminished activity compared to the analogous derivative with carboxyl residues (#20, mesotetra-(4-sulphonatophenyl)-porphyrin). A similar lack of activity was observed with a sulphonated phtalocyanine (#1). Esterification of carboxylic acid residues led to drastic reduction of antiviral activity [compare #13, protoporphyrin IX, with its dimethyl ester (#14)]. Porphyrin derivatives lacking carboxylic acid residues (#17-19, #23, #24, and #26) also had low or no inhibitory activity. a Porptiyrin derivatives with inhibitory activity ;;,30% are indicated by + with the percentage of inhibition of the reaction between gp120 and rabbit antibodies to the HIV-1 IIIB V3 loop peptide (303--338) at a 60 flog ml" concentration given in parentheses.
b ECso = concentration at which the production of P24 was reduced to 50% of that detected in HIV-1-infected cultures in the absence of porphyrins. C COso= concentration at which 50% of uninfected cells were lysed. d SI = selectivity index = concentration of the compound in flog rnl" at which 50% of control, uninfected cells were killed divided by EC so. Substances with SI ;;, 8 and EC so < 8 flog rnl" are printed in italic.
Compound number is indicated in the text by the symbol #.
Diminished antiviral activity of metallaparphyrins
Further studies were carried out to compare the antiviral activity of several porphyrins and the corresponding metalloporphyrins. Cu-and Zn-chlorin e6 were more efficient inhibitors of the reaction between HIV-1-IIIB-gp120 and three distinct antisera specific for the V3 hypervariable loop in comparison with chlorin e6 (Fig. 3) .
On the other hand, incorporation of either Cu or Zn into the porphyrin ring of chlorin e6 resulted in decreased antiviral activity (#4a-c; Table 1 ). Fe in the ring of deuteroporphyrin IX, 2-vinyl-4-hydroxymethyl led to decreased inhibitory activity as measured by serological tests, while incorporation of Zn did not have such effect (Fig. 4) . However, the corresponding two metalloporphyrins had no detectable antiviral activity (#7b,c; Table 1 ). Incorporation of metals into the porphyrin ring of meso-tetra (4-carboxyphenyl) porphine resulted in drastic reduction of inhibitory activity as determined by serological tests (Fig. 6 ). The Co, Cr, Fe, Mn, and Ni derivatives did not inhibit the reaction between gp120 and McAb NEA 9305 and a chimpanzee antiserum specific for the V3 hypervariable loop, respectively, while inhibitory activity was detectable when measured with antiserum to a synthetic peptide corresponding to the full-length V3 hypervariable loop of HIV-1-IIIB gp120. This indicates that epitopes recognized by the respective antibodies are not identical, in agreement with results published elsewhere (Neurath et sl., 1991b) . Metal chelates of meso-tetra (4-carboxyphenyl) porphine had low antiviral activity [50% Effective concentration (EC so ) = 20-33 fL9 rnr ": data not shown]. Incorporation of Cu into the ring of uroporphyrin III resulted in drastic reduction of its inhibitory effect on the reaction between gp120 and anti-V3-loop-specific antibodies, while incorporation of Porphyrins as anti-HIV-1 antiviral agents 59 Fig. 3 . Inhibitory effect of chlorin e6 (60 fL9 rnl') and its metal chelates on the reaction between HIV-1 IIIB glycoprotein gp120 and three distinct antibodies reacting with the V3 hypervariable loop of this glycoprotein. The antisera used were: rabbit antiserum to a synthetic peptide corresponding to the V3 hypervariable loop of HIV-1 clone BH-10, serum of a chimpanzee immunized with V3 hypervariable loop peptides of distinct HIV-1 isolates (Neurath et aI., 1991) and monoclonal antibodies (McAb NEA 9305) raised against a synthetic peptide RIQRGPGRAFVTIGK, corresponding to residues (315-329) of the V3 hypervariable loop of HIV-1 BH-10.
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Inserted metal Zn Zn did not have such effect (Fig. 6) . On the other hand, the incorporation of any of these two metals led to a loss of antiviral activity (#22a-c; Table 1 ). Aluminium phthalocyanine tetrasulphonate (#1) lacked significant inhibitory activity as measured by immunoassays. Chlorophyllin (#25; a Cu"" derivative) was a poor inhibitor of HIV-1 replication. It should also be mentioned that protoporphyrin IX (#13) had a higher antiviral activity (EC so = 1 ""g rnr') in comparison with its Fe derivative, haemin (EC so = 23""g ml": Neurath et al., 1991a) . In conclusion, these results show that metalloporphyrins have a dramatically decreased antiviral activity in comparison with the corres-ponding porphyrins. Except Zn-derivatives and chlorin e6 derivatives, they also had diminished inhibitory activity on the reaction between gp120 and anti-V3-loop antibodies.
Antiviral activity of porphyrins against several HIV-1 isolates
All results presented so far were concerned with a single HIV-1 isolate, IIIB. To be generally useful for antiviral chemotherapy the porphyrin derivatives should react with the V3 hypervariable loop of gp120 corresponding to HIV-1 isolates other than IIIB (= BH-10). In order to Deuteroporphyrin IX, 2-vinyl, 4-hydroxymethyl (60 J,lg/ml) demonstrate that this requirement is indeed met, the inhibitory effect of two selected derivatives, deuteroporphyrin IX, 2,4 (4,2) hydroxyethyl vinyl and meso-tetra (4-carboxyphenyl) porphine on the reaction between synthetic peptides from the V3 hypervariable loop of 21 distinct HIV-1 isolates with homologous antibodies was tested. Results presented in Fig. 1 show that these two compounds inhibited the reaction between the respective peptides and the homologous antibodies. Both ofthese porphyrin derivatives have carboxyl groups, so it was useful to determine whether their inhibitory activity Porphyrins as anti-HIV-1 antiviral agents 61 Fig. 7 . Antiviral activity of selected porphyrin derivatives for distinct HIV-1 isolates in Tlymphocytic (MT-2) and a promonocytic (U937) cell lines. HIV-1 RF did not replicate in U937 cells. Therefore, the antiviral activity against HIV-1 RF could not be tested in this cell line. Note that the height of the columns is inversely proportional to antiviral activity. The ECso values for meso-tetra (4-carboxyphenyl) porphine in MT-2 cells infected with HIV-1 RF and SF-2 were 0.30 and 0.17fL9 
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activity against three additional HIV-1 isolates MN, SF-2 and RF in two different cell lines, U937 and MT-2. All four derivatives inhibited the replication of these virus isolates in the two cell lines tested (Fig. 7) . Cumulatively, the results show that meso-tetra (4-carboxyphenyl) porphine appears to be the porphyrin of choice for further chemotherapeutic evaluations, since it is the most potent inhibitor of HIV-1 replication and has antiviral activity against several HIV-1 isolates.
Discussion
The finding that haemin inhibited the replication of HIV-1 (Levere et al., 1991) , and that it reacted with the V3 hypervariable loop of the virus (Neurath et aI., 1991a) led us to investigate the inhibitory activity on the reaction between gp120 and anti-V3-loop specific antibodies, as well as the antiviral effects, of additional porphyrin derivatives with the following goals: to find more potent inhibitors than haemin; and to establish a relationship between structure and antiviral activity of porphyrin derivatives. Results presented here revealed; that some porphyrins are significantly more potent inhibitors of HIV-1 replication than haemin or aurintricarboxylic acid (ATA), the compound first shown to inhibit the attachment of antibodies specific for the V3 hypervariable loop to the HIV-1 envelope glycoprotein gp120 (Neurath et al., 1991a) ; and that the tetrapyrrole ring itself and carboxyl residues attached to it, are not sufficient to endow porphyrins with anti-HIV-1 antiviral properties, since minor structural changes profoundly affect the antiviral activity of such derivatives, as will be discussed below.
Porphyrin derivatives without carboxyl (or sulphonate) groups were relatively ineffective inhibitors of HIV-1 replication or did not have detectable antiviral activity. However, some of the porphyrins with carboxyls only weakly inhibited the reaction between gp120 and anti-V3 loop antibodies or had only low anti-HIV-1 antiviral activity [for example, coproporphyrin I and III (#2,3), and heptaand penta-carboxylporphyrin (#8, #10)]. Comparison of structures of porphyrins with carboxyl residues, with and without antiviral activity, suggests the following features, necessary for enhancing antiviral properties (Fig. 2) : the presence of adjacent carboxyls [chlorin e6, deuteroporphyrin IX, hexacarboxylporphyrin, protoporphyrin IX and uroporphyrin III];the presence of an extended conjugated system. (That such a system is necessary is evident from the radical changes of activity when metals are coordinated to the porphyrin ring); the presence of vinyl groups (#4a, #6, #7a, #12, #13); and the presenceoffour phenyl rings [meso-tetra (4-carboxyphenyl) porphine], the latter two features apparently extend the conjugated system of the porphyrin ring.
Metalloporphyrins (:::;20 J.Lg mr') were used as 'sensitizers' in photodynamic inactivation of HIV-1 (Matthews et aI., 1988) . They were reported to lack virus-inactivating properties in the absence of exposure to light, in agreement with results reported here. Thus, the virus-inhibitory properties of porphyrins described here can be ascribed to mechanisms other than photoinactivation requiring metalloporphyrins.
The demonstration that some porphyrins [particularly meso-tetra (4-carboxyphenyl) porphine] are potent inhibitors of replication of several HIV-1 isolates suggests the potential of porphyrins for antiviral chemotherapy, and possibly for prophylaxis of HIV-1 infections. An understanding of the relationship between the structure of porphyrins and their antiviral effects, perceptible from the results presented, is expected to lead to the design of additional derivatives with more potent antiviral activity, and to the unravelling of molecular details involved in the association between the V3 loop of gp120 and antiviral compounds targeted to this loop.
Materials and Experimental procedures
Prescreening of porphyrin derivatives for inhibitory activity in the reaction between gp 120 and antibodies to the V3 hypervariable loop Porphyrins listed in Table 1 were obtained from Porphyrin Products Inc., Logan, UT, USA and Midcentury Chemicals, Posen, IL, USA. Chlorophyll a and b, and vitamin B12 (cyanocobalamin) were obtained from Sigma, S1. Louis, MO, USA, and chlorophyllin from Aldrich, Milwaukee, WI, l)SA. They were dissolved in dimethylsulphoxide to a final concentration of 10 mg mr'. Their inhibitory activity for the reaction between gp120 and antibodies to the V3 hypervariable loop was assayed at final concentrations of 180 and 60 JLg ml" , respectively. The inhibitory activity of all substances for the reaction between HIV-1 gp120-IIIB and rabbit antibodies, to the full length V3 hypervariable loop of HIV-1 BH-10, was tested first (Neurath & Strick, 1990; Neurath et el., 1991a) . Compounds which had an inhibitory activity >20% were further assayed for the inhibition of attachment to gp120-IIIB of monoclonal antibody (McAb) 9305 (DuPont, Wilmington, DE, USA) and of antibodies from a chimpanzee immunized with V3 hypervariable loop peptides from distinct isolates (clones) of HIV-1 (Neurath eta/., 1991b) .
Wells of 96-well polystyrene plates (Immulon II, Dynatech Laboratories, Inc., Chantilly, VA, USA) were coated with recombinant HIV-1-IIIB gp120 (500ng well-1 ; American BioTechnologies Inc., Cambridge, MA, USA).After washing with 0.14M NaCI, 0.01 M Tris, 0.02% NaN3 (TS), the wells were postcoated with a mixture of bovine serum albumin (BSA)and gelatin (10 and 2.5 mg mr", respectively) in TS. The wells were incubated with a diluent corresponding to a mixture of foetal bovine serum and goat serum (9: 1) containing 0.1% Tween 20, adjusted to pH 8 (TS-FG)with or without the respective compounds assayed (final concentrations 180 and 60 JLg mr",respectively). After incubation for 30 min at 25°C, antibodies specific for the V3 hypervariable loop of HIV-1-gp120-IIIB were added. They corresponded either to an antiserum to the V3 hypervariable loop of HIV-1-IIIB, a chimpanzee antiserum to V3 hypervariable loop peptides (each added to a final dilution of 1: 1000) or to McAb NEA 9305 (125ng well-1 ) .
After incubation overnight at 25°C, the attached antibodies were quantitated by radioimmunoassays (RIA) or enzyme-linked immunoadsorbent assays (ELISA) as described before (Neurath et el., 1991a) .
Selected porphyrin derivatives were also tested for inhibition of the reaction between V3 hypervariable loop peptides from 21 distinct HIV-1 isolates and the corresponding homologous antipeptide antibodies. These tests were carried out as previously described (Neurath et a/., 1991a) .
The inhibitory effect of the different compounds on the reaction between anti-V3 antibodies and gp120 (or synthetic peptides derived from it) was determined from the formula: {[counts of radioactivity (cpm) in the absence of porphyrin derivatives (pd)cpm in the presence of pd] 7 cpm in the absence of pd} x 100. An analogous formula was used to calculate the percentage of inhibition from optical density readings resulting from ELISAtests.
Screening ofporphyrin derivatives preselected for inhibitory activity by site-specific RIA (ELISA) for antiviral activity All chemicals were tested at serial two-fold dilutions (0.16-80 JLg rnr"). Their inhibitory activity was determined by two distinct methods, based on inhibition of synthesis of core protein P24 and on protection by the compounds of cells against the cytopathic effect of HIV-1 (colorimetric method), respectively. The cytotoxic effect of all compounds in the absence of HIV-1 was also determined by the latter method.
The compounds were serially diluted in RPMI 1640 medium without phenol red (Gibco, Grand Island, NY, USA) containing 10% foetal calf serum (FCS).Aliquots of the diluted solutions were added to wells of 96-well plates and mixed with an equal volume of diluted HIV-1-IIIB [multiplicity of infection (MOl) = 0.0045]. After incubation for 1 hat 37"C, 25 JLI of polybrene (1 JLg mr")treated MT-2 cells (Harada et el., 1985) (5000 cells welr') were added.
The mixture was incubated for 1 h at 37"C and the volume was adjusted with RPMI 1640 medium with 10% FCS to 200 JLI. On the fourth day after incubation at 37"C, 100 JLI of culture supernatants were collected from each well and equal volumes of fresh medium were added to the wells. The supernatants were assayed for P24 using a kit from Coulter Immunology (Hialeah, FL, USA). On the sixth day, an indicator XTT tetrazolium dye (1mg ml-1 ; 50JLI well-1 ; PolySciences Inc., Warrington, PA, USA)was added to the cells. After 4 h, intracellular formazan was determined colorimetrically at 450nm. Selected compounds were tested for antiviral activity also in U937 promonocytic cells, and were also assayed for antiviral activity against HIV-1 isolates MN, SF-2 and RF.
Determination of cytotoxicity mediated by porphyrin derivatives
The cytotoxicity of porphyrin derivatives for uninfected MT-2 cells was also determined by the colorimetric assay with the XTT tetrazolium dye. The procedure was identical to that for detecting HIV-mediated cytopathogenesis, except that the virus suspension was replaced by RPMI 1640 medium. For total cytolysis, the detergent Nonidet P40 (BDH Chemicals Ltd, Poole, UK; final concentration 5mg mr') was added to the wells containing MT-2 cells without porphyrin derivatives. Percent of cytotoxicity was calculated from the following formula: (E-N) 7 (T-N) x 100. 'E' r represents optical density (OD450) in the presence of compounds while 'N' represents that in absence of compounds. 'T' corresponds to OD 4 5 0 resulting from total cytolysis.
